From: Small molecule modulation of microbiota: a systems pharmacology perspective
Categories | p Value | Bonferroni corrected p value | B&H FDR adjusted p value | B&Y FDR adjusted p value |
---|---|---|---|---|
Nitric oxide synthase antagonists & inhibitors | 0.00000 | 0.00012 | 0.00012 | 0.00082 |
Urea | 0.00000 | 0.00029 | 0.00014 | 0.00094 |
Sulfonylureas | 0.00004 | 0.01525 | 0.00508 | 0.03327 |
Oral hypoglycemics | 0.00007 | 0.02843 | 0.00711 | 0.04652 |
Drugs used in diabetes | 0.00018 | 0.06979 | 0.01204 | 0.07882 |
Sulfonylurea compounds | 0.00019 | 0.07226 | 0.01204 | 0.07882 |
Stereoisomerism | 0.00023 | 0.08839 | 0.01263 | 0.08264 |
Aldehyde reductase, antagonists & inhibitors | 0.00041 | 0.16059 | 0.02007 | 0.13138 |
Enzyme inhibitors | 0.00047 | 0.18206 | 0.02023 | 0.13239 |
Blood glucose lowering agents | 0.00061 | 0.23983 | 0.02398 | 0.15696 |
Pyrazoles | 0.00135 | 0.52458 | 0.04769 | 0.31211 |